Treatment with low-dose tacrolimus inhibits bleeding complications in a patient with hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension

by N Sommer, F Droege, KE Gamen, U Geisthoff, H Gall, K Tello, MJ Richter, LM Deubner, R Schmiedel, M Hecker, E Spiekerkoetter, K Wirsching, W Seeger, HA Ghofrani, S Pullamsetti
Published 2018-11-01

Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia

by C. L. Shovlin, C. M. Millar, F. Droege, A. Kjeldsen, G. Manfredi, P. Suppressa, S. Ugolini, N. Coote, A. D. Fialla, U. Geisthoff, G. M. Lenato, H. J. Mager, F. Pagella, M. C. Post, C. Sabbà, U. Sure, P. M. Torring, S. Dupuis-Girod, E. Buscarini, VASCERN-HHT
Published 2019-08-01